TransThera Sciences (Nanjing), Inc.

HK$8.09As of Sun 8 Nov 2026, 12:00 UTC
HKEX:2617Healthcare
Country Hong Kong
PE (Fwd) •••
TSR 10Y CAGR —
Div yield —
ROE (36.78%)
Biotechnology
Beta (5Y) —
PE TTM —
TSR TTM (95.60%)
Mkt cap HK$3.293B
ROIC (23.25%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
$8.98
11.11%
493.77%
Hold 2|5|2|8|0
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.14
0.15
0.14
0.15
26.31%
25.27%
11.42%
10.62%
Revenue¥M
283.8
286.8
279.6
276.4
0.10%
0.64%
(0.88%)
0.68%
Peers (US$420.0M)
Cap (US$)
PE
419.8M
—
Capital
TTM
5Y
10Y
Leveragex
4.705
0.572
0.468
EBIT/Intx
0.619
0.417
0.272
Own earn%
(4.89)
249.83
246.55
Sh yield%
30.74
3.13
4.93
Owners
Insiders/Inst%
1.54
75.12
Short interest%
3.23
SBC / revenue%
1.79
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
18
Op margin range%
0–5
$1 testx
0.0
Incr. ROIC%
3